ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer

BACKGROUND: Anillin (ANLN), an actin-binding protein required for cytokinesis, has recently been presented as part of a prognostic marker panel in breast cancer. The objective of the current study was to further explore the prognostic and functional value of ANLN as a single biomarker in breast canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Magnusson, Kristina, Gremel, Gabriela, Rydén, Lisa, Pontén, Victor, Uhlén, Mathias, Dimberg, Anna, Jirström, Karin, Pontén, Fredrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116155/
https://www.ncbi.nlm.nih.gov/pubmed/27863473
http://dx.doi.org/10.1186/s12885-016-2923-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116155/
https://www.ncbi.nlm.nih.gov/pubmed/27863473
http://dx.doi.org/10.1186/s12885-016-2923-8

Ejemplares similares